Picture of Nexalin Technology logo

NXL — Nexalin Technology News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Nexalin Technology Announces Positive Clinical Study Data In Major Depressive Disorder

June 26 (Reuters) - Nexalin Technology Inc  NXL.O :
    * NEXALIN TECHNOLOGY ANNOUNCES POSITIVE CLINICAL STUDY DATA
IN
MAJOR DEPRESSIVE DISORDER AND PUBLICATION OF CLINICAL TRIAL
RESULTS IN LEADING SCIENTIFIC JOURNAL
    * NEXALIN TECHNOLOGY: STUDY SHOWS STRONG STATISTICAL
SEPARATION
BETWEEN PATIENTS RECEIVING NEXALIN'S DIFS TECHNOLOGY WITH
ESCITALOPRAM VERSUS SHAM GROUP
    * NEXALIN TECHNOLOGY INC - NO SERIOUS ADVERSE EVENTS
OBSERVED IN
TRIAL

Source text for Eikon:  ID:nGNX6tJyG3 
Further company coverage:  NXL.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Nexalin Technology

See all news